Skip to main content
Clinical Trials/NCT00519610
NCT00519610
Completed
Not Applicable

A Study Assessing Patient Outcomes After Placement of H-graft Portacaval Shunts for the Treatment of Portal Hypertension

University of South Florida1 site in 1 country66 target enrollmentJuly 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Portal Hypertension
Sponsor
University of South Florida
Enrollment
66
Locations
1
Primary Endpoint
The objective of this study is to evaluate the pre-operative symptoms and medical history of patients with portal hypertension who have undergone placement of H-graft portacaval shunts and correlate this with patient outcomes.
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The objective of this study is to evaluate the pre-operative symptoms and medical history of patients with portal hypertension who have undergone placement of H-graft portacaval shunts and correlate this with patient outcomes.

Detailed Description

Research data will be collected by accessing the Tampa General Hospital medical record charts as well as the Harbourside medical charts, and extracting the necessary research data. The charts will be reviewed for the relevant medical information in order to assess outcomes in patients having H-graft shunts placed for the treatment of portal hypertension.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
July 2010
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kenneth Luberice

Clinical Research Coordinator

University of South Florida

Eligibility Criteria

Inclusion Criteria

  • Patients who have had H-graft shunts placed for the treatment of portal hypertension.

Exclusion Criteria

  • Patients under the age of 18 will not be included in this study.

Outcomes

Primary Outcomes

The objective of this study is to evaluate the pre-operative symptoms and medical history of patients with portal hypertension who have undergone placement of H-graft portacaval shunts and correlate this with patient outcomes.

Time Frame: 5 years

Study Sites (1)

Loading locations...

Similar Trials